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Abstract 
The Lactic acid bacteria (LAB) Lactobacillus acidophilus sp. 5e2 and Lactobacillus 
helveticus sp. Rosyjski both secrete exopolysaccharides (EPSs) into their 
surrounding environments during growth. A number of EPSs have previously been 
shown to exhibit immunomodulatory activity with professional immune cells, such as 
macrophages, but only limited studies have been reported of their interaction with 
intestinal epithelial cells. An investigation of the immunomodulatory potential of pure 
EPSs, isolated from cultures of Lactobacillus acidophilus sp. 5e2 and Lactobacillus 
helveticus sp. Rosyjski, with the HT29-19A intestinal epithelial cell line are reported 
here. For the first time the structure of the EPS from Lactobacillus helveticus sp. 
Rosyjski which is a hetropolysaccharide with a branched pentasaccharide repeat unit 
containing D-glucose, D-galactose and N-acetyl-D-mannosamine is described. In 
response to exposure to lactobacilli EPSs HT29-19A cells produce significantly 
increased levels of the proinflammatory cytokine IL-8. Additionally, the EPSs 
differentially modulate the mRNA expression of Toll-like receptors. Finally, the pre-
treatment of HT29-19A cells with the EPSs sensitises the cells to subsequent 
challenge with bacterial antigens. The results reported here suggest that EPSs could 
potentially play a role in intestinal homeostasis via a specific interaction with 
intestinal epithelial cells.  
 
 
 
 
Key words: lactobacilli, exopolysaccharides, intestinal epithelial cells, innate 
immunity, Toll-like receptors 
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1. Introduction 
Exopolysaccharides (EPSs) are long-chain polysaccharides naturally released by a 
variety of both Gram-positive and Gram-negative bacteria during growth1-3. EPSs 
play a major role in bacterial attachment and biofilm formation4-6 and it is has been 
shown that EPS-deficient mutants completely lack the ability to form biofilms in 
vitro7,8. Additionally, they are thought to be responsible for enhancing nutrient and 
water entrapping abilities of bacteria4. The inclusion of EPSs and EPS producing 
bacteria in food and food supplements is becoming more common, originally they 
were added as biothickening agents9,10 and as moisture retention agents11. 
However, more recently there have been an increasing number of reports claiming 
health benefits associated with the consumption of EPS producing bacteria: mostly 
lactic acid bacteria (LAB) and bifidobacteria12 13-17. 
Those EPSs which are synthesised at the cell membrane and subsequently 
released into the surrounding media frequently contain multiple repeats of 
oligosaccharides (repeating units) made up of between 3 and 7 sugar residues. The 
repeating units typically contain D-glucose, D-galactose and L-rhamnose sugars and 
occasionally include amino-sugars, such as N-acetyl-D-glucosamine and N-acetyl-D-
galactosamine9,18. EPSs are produced by a number of mesophilic and thermophilic 
bacteria, including LAB19 and bifidobacteria2. 
A high proportion of bacteria used in the food industry and indeed, naturally 
residing within the intestine, such as LAB and bifidobacteria, are EPS-producing thus 
it is surprising that very little research has been undertaken into the 
immunomodulatory potential of EPSs with the intestinal epithelial layer, particularly 
as it is known that EPSs can survive transit through the gastrointestinal tract20. EPSs 
have previously been considered in immunomodulatory studies utilising macrophage 
4 
 
cell models, with the up-regulation of both pro- and anti-inflammatory cytokines, such 
as TNF-, IL-6 and IL-10, observed in response to challenge with EPSs13-15,17. It has 
been suggested that these differential effects could be correlated with 
physiochemical properties with large EPSs suppressing the immune response and 
those with acidic groups stimulating macrophages.21 Despite this, the mechanism 
with which EPSs interact with intestinal epithelial cells is unknown; however, Toll-like 
receptors (TLRs) of the innate immune system, including intestinal epithelial cells 
have recently been suggested to mediate these responses22. 
Lactobacillus helveticus sp. Rosyjski is a strain of EPS-producing Gram 
positive bacteria identified by the EU International Scientific Cooperation Project 
(IC15-CT98-0905) (http://imol.vub.ac.be/IMDO/projects/EPSLAB.html) for which 
there is no information on its structural and possible biological activities. In this 
paper, the results of experiments undertaken in order to characterise this novel EPS 
and to investigate its immune modulation activity in cultured intestinal epithelial cells 
is described. In addition, its immunomodulatory potential is compared with that of an 
EPS isolated from Lactobacillus acidophilus sp. 5e2 the structure of which has been 
previously described23. 
5 
 
2. Results and Discussion 
2.1 Structure of the exopolysaccharide isolated L. helveticus sp. Rosyjski- The EPS 
isolated from strain L. helveticus sp. Rosyjski eluted as a single relatively sharp peak 
from a size exclusion column and has a mass average molecular mass (Mw) of about 
1.0 x 106 u. Monomer analysis and determination of the absolute configuration of 
sugars as their 2-butyl glycosides identified D-glucose, D-galactose and N-acetyl-D-
mannosamine in the ratio of 2:2:1 as the component of the repeating unit. The 
presence of N-acetyl-D-mannosamine is unusual as there have been no previous 
reports of LAB EPSs containing this monomer18. The linkage pattern of the 
monomers in the repeating unit was determined using methylation analysis which 
showed the presence of a terminal hexosamine, a terminal hexose, a 1,4-substituted 
hexose and two 1,3,4-substituted hexoses. Finally, the sequence of monomers and 
the establishment of the anomeric configuration of the sugars were determined by a 
detailed analysis of a number of 1D and 2D-NMR. 
Analysis of the anomeric region of the 1H-NMR (Fig. 1 δ =4.5-6 ppm) identified six 
proton resonances: five are anomeric H-1 signals (labelled A to E with decreasing 
chemical shift) and the remaining signal was identified as H-2 of monomer B 
(identified through inspection of cross peaks in the 1H-1H COSY spectrum-not 
shown). In a number of batches of the EPS a small anomeric signal was observed at 
δ =5.31; it is believed that this is due to the loss of the N-acetyl group from N-acetyl-
D-mannosamine during the isolation procedure. The presence of five major anomeric 
protons suggests that the repeating unit is a pentasaccharide. The 13C 135 DEPT 
spectrum (Fig. 1b) contains five signals in the anomeric region confirming that the 
EPS has a pentasaccharide repeat unit. The presence of a carbonyl carbon in the 
13C spectrum (not shown), a high field ring carbon at 53.86 ppm and an acetyl-
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methyl group at 21 ppm confirmed the presence of an N-acetyl-aminosugar. From 
inspection of the negative peaks in the DEPT 135 spectrum it is clear that all five 
sugars are hexoses and that there are no 1-6 links present in the repeating unit. The 
position of the remaining ring protons was established through analysis of the scalar 
coupling observed in the corresponding 1H-1H COSY spectrum and 1H-1H TOCSY 
spectrum (mixing times 30-250 ms -not shown). 
 
Figure 1 here. 
 
The assignment of individual carbon resonances to their position (1-6) within 
monomers (A-E) was based on inspection of both the 1H-13C HSQC (Fig 2) and 13C 
1H-HSQC-TOCSY spectra (not shown) and the assignments are tabulated in Table 
1.  
Table 1 here. 
The location of C2 of B at 53.86 ppm confirms that residue B is the terminal N-
acetyl-D-mannosamine, the high chemical shifts of both C3 and C4 of residues A and 
C confirm that these are the 1,3,4-linked hexoses. Similarly, the high chemical shift 
of C4 in residue D suggests that this is the 1,4-linked hexose. Finally, the resonance 
position for all the carbons of residue E are those expected for a terminal hexose. 
One way of differentiating between galacto- and glucopyranoses is from inspection 
of the chemical shifts for their H-4 resonances: for a galactose H-4 is shifted 
substantially to lower field than that of glucose, regardless of the anomeric 
configuration and linkage. Data collected from assignments for LAB EPS structures 
show that the H-4 resonances for galactose lie in the range 4.30-3.85 δ whilst those 
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for glucose lie in the range 3.45 -3.75δ. The latter result would strongly suggest that 
residues A & C are galactose and D & E are glucose; this assignment is supported 
by the failure to get transmission of the scalar coupling beyond H-4 in both residues 
A and C and by the intra-residue NOEs observed in the ROESY spectrum (not 
shown). 
The anomeric configuration of each of the monomers was determined by 
measurement of the magnitude of the 1JC1-H1 coupling constant measured using a 
coupled HSQC spectrum (not shown): A (172 Hz), B (166 Hz), C (177 Hz) D (157Hz) 
and E (164Hz). With values greater than 170 Hz for A & C represent monomers 
having α-linkages whilst, with values less than 170 Hz for monomers B, D & E will 
have β-linkages. Finally, the sequence of the monomers in the repeating unit was 
determined by examination of the HMBC (Fig. 3) and ROSEY spectra (not shown); 
the most significant intra- and inter-residue cross-peaks are highlighted on the 
HMBC spectrum. 
Figures 3  
 
The combined results of the chemical and spectroscopic analysis identify that the 
repeating unit of the EPS from L. helveticus sp. Rosyjski has the following novel 
structure: 
 
Figure 4 here: 
 
2.2 Purity of the isolated EPS-Before measuring the biological activity of the EPSs 
from Lactobacillus acidophilus sp. 5e2 and Lactobacillus helveticus sp. Rosyjski it 
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was necessary to confirm the purity of the samples. The first step in the isolation 
procedure involved the removal of cells by ultracentrifugation to provide a clear 
supernatant containing only material that had been secreted into the fermentation 
media. Careful collection of the EPS from the fermentation media during the log 
growth phase was done deliberately to minimise contamination by cell wall 
components. The carbohydrate content of batches of EPS was measured and those 
having greater than 80% carbohydrate content were used in the biological assays. 
The vast majority of the remaining mass of the samples was determined to be water 
of hydration; the measured protein content was less than 2% (typically 0.5%) and the 
nucleic acids content was less than 0.5%. The samples were analysed by SEC-
MALLS which demonstrated that a single high mass polysaccharide was being 
isolated and the in-line UV detector confirmed the very low levels of protein and 
nucleic acid contamination.  Proton, carbon and phosphorus NMR indicated that the 
EPS was the only macromolecule present. The absence of any phosphorus signals 
in the 31P NMR identifies that cell wall components are not present even at low 
concentrations.  
Whilst we cannot completely rule out that small levels of impurities are responsible 
for some of the biological activity that is observed; it is highly unlikely that this is the 
case. The choice of Gram positive bacteria lacking flaggellin, the method of isolation 
of the EPS and the processes used for its purification have been developed in order 
to reduce as far as possible the contamination of the EPS by bacterial cell wall 
antigens. 
 
2.3 Immunomodulatory activity of Lactobacilli EPS the effect of exposure on 
chemokine production- The enteric microflora is thought to play a key role in 
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intestinal homeostasis24, with non-pathogenic bacteria, such as lactobacilli and 
bifidobacteria, characterised by their differential stimulation of intestinal epithelial 
cells 25-27 and intestinal-associated immune cells, such as dendritic cells and 
macrophages28,29.. In addition to being part of the normal enteric microflora specific 
strains of lactobacilli and bifidobacteria are the most commonly used probiotic 
bacteria. Previously, EPSs isolated from such bacteria have shown 
immunomodulatory activity with immune cells such as macrophages and 
lymphocytes13-15,17.  However, the first line of defence in the intestinal tract is the 
epithelial layer, a one-cell thick barrier which lines the lumen of the gut;  however, 
the potential of EPSs to interact with these cells has been neglected. A recent review 
article, considered the potential of EPS interacting with the epithelial layer21 and 
presented preliminary data showing that bifidobacteria EPSs can stimulate the 
release of inflammatory cytokines, such as IL-6 and IL-8, in an intestinal epithelial 
cell line (Caco-2)21.  
In the experiments reported here lactobacilli EPS were applied directly to HT2919A 
cells. This cell line was chosen because it has previously been shown that these 
cells expresses a full complement of pattern recognition receptors (PRR) and that 
these are coupled to cytokine responses30,31. It is important to note that HT2919A 
cells are not ‘professional immune cells’ and that they require a challenge from a 
substantially higher concentrations of bacterial antigens before a biological response 
is observed. Despite this the EPSs from L. helveticus sp. Rosyjski stimulated a 
small, yet statistically significant (p  0.01), increase in expression of the 
proinflammatory chemokine, IL-8, (Fig. 5a), and increased levels of IL-8mRNA (up-
regulated ~4-fold, p 0.05, Fig. 5b). In addition, despite the recently discovered 
potential of HT29 cells to secrete the anti-inflammatory cytokine, IL-1032, the L. 
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helveticus sp. Rosyjski EPS did not stimulate either mRNA or protein expression of 
IL-10 (data not shown).  
 
Figures 5a and 5b here 
 
As a direct comparison, we studied the effect on intestinal epithelial cells of the EPS 
from a separate strain of lactobacilli, L. acidophilus sp. 5e2 the structure of which 
has been previously described23 and reproduced here (Fig. 6). It is also a neutral 
EPS but with a smaller molecular mass of 4.5 x 105 u and has a heptasaccharide 
repeating unit composed of D-glucose, D-galactose and N-acetyl-D-glucosamine in 
the molar ratio 3:3:1 but its biological activity was unknown. A similar effect on the 
immune response of intestinal epithelial cells was found for the EPS isolated from L. 
acidophilus sp. 5e2 EPS as occurred with L. helveticus sp. Rosyjski (Fig. 5). Both 
EPSs were used in the cell assays at a final concentration (20 µg/ml) similar to that 
which has been reported to accumulate in the culture media of a number of EPS 
producing strains of lactobacillus33. As the concentration of EPS is relatively high, it 
could be argued that the levels of impurities will be above those where they might be 
expected to contribute to the observed biological activity; indeed this would be true 
for macrophages, however, much higher concentrations of protein and nucleic acid 
antigens would be needed before a response from epithelial HT2919A cells could be 
expected. 
Previously, evidence has been presented that the immunomodulatory effects of 
EPSs could be related to their physiochemical properties with a tendency for those 
that are charged to stimulate an immune response in highly immunogenic cells types 
such as macrophages and splenic cells and conversely, large neutral structures 
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suppress immunity21. In contrast to this the two novel neutral EPSs that we have 
studied both stimulate a small increase in the proinflammatory cytokine IL-8 in an in 
vitro model of the intestinal epithelia. Intestinal epithelial cells represent the frontline 
innate immune defence against the enteric microflora and have previously been 
shown to release IL-8 in response to bacteria34 and their products35, however, they 
are not professional immune cells and this could account for the discrepancy.  
If the results presented here that indicate EPSs can stimulate low-levels of 
proinflammatory IL-8 from intestinal epithelial cells are reproduced in vivo, it would 
suggest a potential beneficial effect for gut homeostasis. Because the EPSs could 
compete with more active inflammatory mediators for host pattern recognition 
receptors (PRRs), such as Toll-like receptors (TLRs), and thus reduce excessive 
inflammation. Additionally, the low level of IL-8 secretion reported here could, 
somewhat paradoxically, be beneficial, priming the intestine and thus allowing a 
more controlled and rapid response to pathogenic bacteria.  
As previously stated there is very little information on the receptors which mediate 
the cellular activity of EPSs, although it is suspected that this is via the TLR family, it 
was therefore decided to study the effect of the two EPSs on TLR mRNA expression. 
On incubation of HT29-19A cells with 20 g/ml of L. acidophilus sp. 5e2 EPS for 24 
h, mRNA expression of TLRs-1, -2, -5 and -9 was significantly (p  0.05) increased 
(Fig. 7). However, despite a ~3-fold increase, the change in expression of TLR-4 
mRNA was not statistically different from the control level (Fig. 7). Cells challenged 
with L. helveticus sp. Rosyjski EPS, showed significant (p  0.05) up-regulation of 
TLRs-1, -2, -4 and -5 mRNA, (Fig. 7). In contrast, TLR-9 mRNA expression was 
down-regulated, such that no detectable levels were observed (Fig. 7). It is very 
clear from the current results that when challenged with the EPSs, HT29-19A cells 
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exhibited a very significant up-regulation of TLR-2 mRNA expression (Fig. 7). It has 
previously been reported that upon binding their cognate receptor, TLR agonists 
have been shown to cause an up-regulation of the receptor in question 36-38, 
therefore, we can hypothesise that the up-regulation of TLR-2 mRNA is due to direct 
association of the EPSs with TLR-2 
 
Figure 6 here 
 
2.4 Monitoring the ability of lactobacilli EPS to prime the immunomodulatory activity 
of epithelial cells to subsequent challenge by bacterial antigens. 
Currently, little is known of the cellular pathways involved in the interaction of 
bacterial SPSs with cells of host organisms. However, a recent study on a novel EPS 
(TA-1) isolated from the thermophilic marine bacterium, Thermus aquaticus, was 
shown to stimulate the release of proinflammatory cytokines, TNF- and IL-6, from 
murine macrophages via a TLR-2-mediated pathway22. This is consistent with the 
fact that TLR-2 is well characterised in its interactions with a diverse range of 
microbial components39,40. A number of bacterial cell wall components such as 
lipopolysaccharides (LPS), flagellin and peptidoglycan (PGN) are known to activate 
the immune response, through their action as ligands for Toll-like receptors on 
intestinal epithelial cells. The specific receptors mediating cellular responses to the 
agonists tested here are: LPS for TLR 4, flagellin for TLR 5, and PGN for TLR 2; 
additionally an agonist for TLR 9, CpG oligodeoxynucleotide (ODN) of bacterial 
origin was also tested. Aberrant responses to these bacterial antigens are believed 
to play a key role in the pathogenesis of inflammatory bowel diseases, therefore, we 
were interested to see if exposure to EPSs could modulate the cellular response to 
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these. Cells which were pre-treated with 20 g/ml of EPSs for 24 h and subsequently 
challenged with peptidoglycan (PGN; 500 g/ml) exhibited a small but statistically 
significant (p < 0.05) increase in IL-8 release, when compared to cells pre-treated 
with cell culture media alone (Fig. 8). Additionally, cells pre-treated with L. helveticus 
sp. Rosyjski EPS and challenged with flagellin (100 ng/ml) afterwards, secreted 
significantly (p < 0.05) increased levels of IL-8 (Fig 8).  
 
The results of these experiments suggest that the up-regulation of TLR-2 appears to 
‘sensitise’ the epithelial cells to subsequent challenge with the known TLR-2 agonist, 
PGN, with a small but measured increase in the secretion of IL-8; a phenomena 
which again if repeated in vivo could potentially lead epithelial cells to produce a 
more rapid and significant immune response. Previously, live lactobacilli have been 
shown to up-regulate expression of non-cognate TLRs in intestinal epithelial cells, 
thus sensitising them to subsequent challenge with bacterial antigens25,27. The same 
phenomenon was observed in this investigation, with L. helveticus sp. Rosyjski EPS 
sensitising the epithelial cell line to subsequent challenge with bacterial flagellin, 
causing a significant increase in IL-8 release, despite the fact that no increase in 
mRNA expression of TLR5, the receptor which is thought to mediate the 
inflammatory effects of flagellin41, was observed. Nevertheless, this sensitisation 
could potentially be of clinical importance because flagellin plays an important role in 
gut immunity, and is known to be involved in both homeostatic regulation of immune 
responses to the commensal microflora42 and the pathogenesis of inflammatory 
bowel disease43. Indeed, Lodes et al.43 showed flagellin to be a dominant antigen in 
patients with Crohn’s disease. The mechanism for the sensitisation of epithelial cells 
to bacterial products is currently unknown; however, it is thought that stimulation of 
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the common intracellular pathways involved in transduction of TLR-stimulated 
signals may be responsible27. Through this method, EPSs could potentially play a 
role in priming the epithelial layer to pathogen attack, heightening the inflammatory 
response. 
 
Importantly, the present data indicates that exposure to these EPSs result in the 
increase of mRNA for other TLRs involved in bacterial recognition, and thus they 
would have the potential to sensitise the intestinal epithelial cells to various PAMP’s. 
However, at the same time they had limited effect on the potential of the range of 
bacterial products tested here to stimulate IL-8 secretion in HT29 cells. Taken 
together these data indicate a possible beneficial role for these EPSs in modulating 
intestinal inflammation via a direct interaction with the intestinal epithelium. 
 
In conclusion, the structure of a novel EPS isolated from a strain of lactobacillus 
which uniquely contains N-acetyl-D-mannosamine has been determined. In addition, 
evidence has been presented which suggests that the EPSs isolated from lactobacilli 
interact with HT29-19A intestinal epithelial cells, stimulating IL-8 expression at both 
the transcriptional and translational level. It has also been shown that these EPSs 
modulate TLR mRNA expression in the epithelial cell line, resulting in ‘priming’ of the 
cells and an increased release of IL-8 in response to subsequent challenge with the 
bacterial antigens peptidoglycan and flagellin. 
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3. Experimental 
3.1 Materials- HT29-19A intestinal epithelial cells (passages 41-70) were kindly 
donated by Prof. G. Warhurst, Salford Royal NHS Foundation Trust & University of 
Salford and cultured using standard techniques (30). Cell culture media ingredients 
were all purchased from Gibco® Invitrogen™ Life Technologies Ltd.(Paisley, UK). 
Cells were cultured in a standard media of high glucose (4500mg/l) Dulbecco’s 
Modified Eagles Media (DMEM), 10% foetal bovine serum (FBS), 4 mM glutamine 
and a mixture of 50 IU/ml penicillin and 50 µg/ml streptomycin (PenStrep), 
supplemented with 20mM HEPES. Cells were seeded at a density of 0.5 x 105 
cells/cm2 and cultured to confluence (7 days) in 35 mm x 10 mm cell culture dishes. 
Cultures of the bacteria, Lactobacillus acidophilus sp. 5e2 and Lactobacillus 
helveticus sp. Rosyjski, were donated by Rhodia food Biolacta-Texel (Olsztyn, 
Poland), and were maintained on MRSc agar (Lab M Ltd., Lancashire, UK), at 37°C 
in anaerobic conditions. The TLR ligands peptidoglycan (PGN) isolated from Bacillus 
subtilis and deoxyribonucleic acid sodium salt (CpG DNA) from Escherichia coli 
strain B were purchased from Sigma-Aldrich Company Ltd. (Poole, Dorset, UK). 
Flagellin from Salmonella typhimurium strain 14028 was from Enzo Life Sciences 
Ltd. (Exeter, UK). Lipopolysaccharide (LPS) was isolated from E. coli C25 using the 
LPS Extraction Kit from Chembio Ltd. (Hertfordshire, UK). All other reagents were 
purchased from Sigma-Aldrich Company Ltd. (Poole, Dorset, UK) and were used as 
supplied. 
 
3.2 EPS isolation and purification-The multistep extraction and purification of EPSs 
from lactobacilli cultures used here has been described previously10. Briefly, L. 
helveticus sp. Rosyjski was cultured in 10% (w/v) skimmed milk solution (St. Ivel 
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Ltd., Swindon, UK) supplemented with 0.166 M glucose for 24 h at 42 °C. The 
resultant culture was used to inoculate, at 1% (v/v) concentration, a large volume 
(between 1 & 2L, depending on batch number) of skimmed milk solution, 
supplemented with 0.166 M glucose and fermented for 48h at 42°C. Fermentation 
was stopped with the addition of 80% (w/v) trichloroacetic acid (TCA), giving a final 
concentration of 14% (v/v) of TCA, and the resulting solution was stored overnight at 
4°C. The solution was then centrifuged at 25,000g (Avanti J-26 XPI centrifuge, 
Beckman Coulter Ltd, High Wycombe, UK) for 35 mins at 4°C to remove bacteria 
and precipitated proteins. The solution was then filtered through grade 4 filter paper 
(Whatman UK Ltd, Kent, UK), and crude EPS was precipitated by the addition of an 
equal volume of chilled absolute ethanol; this was stored overnight at 4°C. The 
sample was then centrifuged at 25,000g for 35 mins at 4°C. The recovered pellet 
was re-dissolved in deionised water (~50 ml). Gentle heating in a water bath at 50°C 
was required for complete dissolution of the pellet. The dissolved crude EPS was 
subjected to another precipitation step followed by subsequent centrifugation as 
described above. The pellet obtained was then re-dissolved in a minimum of 
deionised water (~10 mL); again gentle heating in a water bath at 50°C was required 
for complete dissolution of the pellet. Small neutral sugars were then removed by 
dialysis, for 72 h at 4°C, against three changes of deionised water per day. After 
three days, the contents of the dialysis tubing was collected in a round-bottom flask 
and lyophilised. The dry mass of the EPS produced was then determined.  
 
3.3 Measurement of purity and mass average molecular mass Mw- the purity of the 
EPS was determined using a combination of biochemical methods and SEC-MALLS 
and NMR analysis. The carbohydrate content was determined using the procedures 
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described by Dubois et al44, the protein content was measured using the Bradford 
assay45 and the nucleic acid content was determined spectrophometrically using 
SEC-MALLS linked to a UV detector (A260 nm) with prior calibration of the 
instrument using a DNA ladder purchased from Promega UK (Southampton, UK). 
The water content of solid EPS samples was determined using a Karl-Fischer 
autotitrator. The phosphorus content of each batch of the EPSs was monitored using 
31P-NMR. 
For determination of the mass average molecular mass by SEC-MALLS, solutions of 
EPS in deionised water (1 mg mL-1) were prepared and left for 24 h to completely 
dissolve. Samples (100 µl) were injected onto an analytical SEC system comprising 
three columns Aquagel-OH 40, 50 and 60 (15 µm particle size, 25 cm x 4 mm, 
Varian, Oxford, UK) connected in series. The neutral analytes were eluted with 
deionised water flowing at 1 mL min-1. The concentration of the EPS fractions eluting 
from the column were determined by a differential refractometer (Optilab rEX, Wyatt 
technology, Santa Barbara, USA, fitted with 16 photodetectors at different angles) 
and the mass average molecular mass was measured using a Dawn-EOS MALLS 
operating with a 690 nm laser (Wyatt technology, Santa Barbara). The Astra 
software was used to analyze the light scattering data using the Zimm method. 
3.4 Monomer composition and linkages of the -EPS For sugar composition 
determinations polysaccharides were hydrolyzed by treatment with 2M TFA (120 °C 
for 2 h); the released sugars were converted to their alditol acetates and analyzed by 
GC-MS. The relative proportions of the different sugars were determined by 
consideration of the total ion count for the different alditol acetates and by 
comparison with the ion count determined for a mixture of alditol acetates. GC-MS 
analyses were performed on a Thermo (Finnigan) Polaris Q-Trace 2000 GC-MS, 
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(Hemel Hempstead, UK). The samples were eluted from a SGE column (BPX5, 25 m 
x 0.32 mm-id, 0.5 µm film; HP5, 15m x 0.32mm-id) eluting with helium (9 psi, flow 
rate 1ml.min-1) and using a temperature programme (start temperature 150 °C, hold 
time 4 min., and a final column temperature of 250 °C reached via a rising gradient 
of 4 °C/min.). Under the standard conditions for the analysis of monomers the 
integral area for the amino-sugar was very small this is a consequence of on column 
thermal decomposition, problems with the analysis of amino sugars has been well 
documented; the final monomer ratio was taken from integration of the NMR peak 
integrals for the respective anomeric protons. The absolute configurations of 
monosaccharides were determined by conversion to their butyl glycosides using the 
procedure described by Gerwig et al46. 
For linkage analysis, the EPS was permethylated using the procedures described by 
Stellner et al47. The methylated-polysaccharide was hydrolysed by treatment with 2M 
TFA (120 °C for 2 h) and the methylated monosaccharides converted to their 
corresponding methylated alditol acetates. The identity of the variously methylated 
alditol acetates was determined by GLC-MS and by analysis of the individual 
fragmentation patterns observed in the MS. GLC-MS analyses were performed on 
an Agilent 7890A GC system (Santa Clara, CA, USA) coupled to an Agilent 5675c 
quadrupole MS. The samples were eluted from a HP-5 column (30 m x 0.25 mm-id, 
0.25 µm film) using helium as carrier (9 psi, flow rate 1 mL min-1) and using the 
following temperature programme: start temperature 155°C, hold time 1 min, and a 
final column temperature of 195°C reached via a rising gradient of 0.75°C min-1.  
3.5 NMR analysis of the EPS from L. helveticus sp. Rosyski - NMR spectra were 
recorded for EPS samples that were dissolved (10 mg mL-1) directly in D2O (Goss 
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Scientific Instruments Ltd., Essex, UK). NMR spectra were recorded at a probe 
temperature of 70°C. The elevated temperature was initially chosen as it shifted the 
HOD signal to higher field, into a clear region of the spectrum. The higher 
temperature also increased spectral resolution by reducing the sample viscosity. All 
of the NMR spectra were recorded on a Bruker Avance 500.13 MHz 1H (125.75 MHz 
13C) spectrometer (Bruker-biospin, Coventry, UK) operating with Z-field gradients 
where appropriate, and using Bruker’s pulse programs. Chemical shifts are 
expressed in ppm relative to either internal or external acetone; δ 2.225 for 1H and δ 
31.55 for 13C. The 2D gs-DQF-COSY spectrum was recorded in magnitude mode at 
70°C. TOCSY experiments were recorded with variable mixing times (60, 90, 120 
ms). The 2D-heteronuclear 1H-13C HSQC, and phase sensitive HSQC-TOCSY 
spectra were recorded using Bruker pulse sequences and 256 experiments of 1024 
data points. The NOESY spectrum was recorded using a Bruker pulse sequence and 
256 experiments of 1024 data points using a mixing time of 200 ms. For the majority 
of spectra, time-domain data were multiplied by phase-shifted (squared-) sine-bell 
functions. After applying zero-filling and Fourier transformation, data sets of 1024-
1024 points were obtained. 
 
3.6 Biological Assays- IL-8 stimulation and analysis EPSs were reconstituted in 
ultrapure water to give a final concentration of 1 mg/ml. HT29-19A cells were 
challenged with 20 g/ml EPSs for 24h. Supernatants were collected and frozen at -
80°C until assayed for IL-8 and IL-10 by ELISA (IL-8 and IL-10 Human Antibody 
Pairs, Invitrogen, Paisley, UK.). Analysis was carried out according to the 
manufacturer’s instructions.  
20 
 
For investigation of TLR ligand stimulation with EPS-pre-treatment, HT29-19A cells 
were challenged 20 g/ml EPSs for 24 h, at 37°C, 5% CO2 and constant humidity. 
Supernatants were removed and cells were subsequently challenged with either 
PGN (500 g/ml), LPS (1000 ng/ml), flagellin (100 ng/ml) or CpG DNA (50g/ml) for 
24 h, at 37°C, 5% CO2 and constant humidity. Supernatants were collected and 
frozen at -80°C until assayed for IL-8 by ELISA. 
For Quantitative real-time (qRT)-PCR total RNA was extracted from cell layers 
previously challenged with 20 g/ml EPSs for 24 h using the RNeasy® Mini Kit and 
RNase-free DNase Set (Qiagen, Crawley, UK). The concentration was measured 
using the absorbance at 260 nm (A260) x 44 g/ml x dilution factor and the purity 
was measured using A260/A280. mRNA was converted to cDNA by the iScript™ 
cDNA Synthesis Kit from Bio-Rad Laboratories Ltd., (Hemel Hempstead, UK). All 
PCR primers (Table 1) were purchased from Eurofins MWG Operon (Ebersberg, 
Germany). Universal ProbeLibrary probes and Lightcycler® Taqman® Master Mix 
were purchased from Roche Diagnostics Ltd.( West Sussex, UK). Amplification was 
carried out in 20 l final volume, containing 1.5l cDNA , 0.5 l F-primer and R-
primer (0.4 M), 0.5 l Universal probe, 4 l Mastermix (5x) and 13 l 
DNase/RNase-free water. The following program was used: (i) activation of the PCR 
polymerase at 95 °C for 10 min (ii) amplification included 45 cycles of denaturation at 
95 °C for 10 s, annealing at 60 °C for 30 s and extension at 72 °C for 1 s (iii) cooling 
at 40 °C for 30 s. Target gene expression was normalised to the housekeeping 
genes GAPDH and -actin and fold difference of expression from the control was 
calculating using the 2-Ct method. 
3.7 Statistical Analysis- Results are expressed as mean ± SEM for the specified 
number of experimental repeats (n). Statistical significance is resolved using 
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unpaired Student’s t-test or ANOVA with Tukey’s post hoc analysis and defined as a 
p value  0.05 and/or p value  0.01. All statistical analyses were undertaken using 
PASW® Statistics 17 (IBM, Armonk, NY, USA). 
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